Evidence map›Paper›PMID 19108800›Full record

ReviewClinical therapeutics2008

Optimizing oral medications for children.

Julie A Mennella, Gary K Beauchamp

Open access · greenAbstract readReview
In one paragraph

Review in Clinical therapeutics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 184 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Julie A MennellaMonell Chemical Senses Center, Philadelphia, Pennsylvania 19104, USA. mennella@monell.org
Gary K Beauchamp
Monell Chemical Senses Center · US

Funding

Sensory/Medical CoreP50DC006760 · NIDCD · MONELL CHEMICAL SENSES CENTER · PI BEAUCHAMP, GARY K · 2004 to 2009
$8.6M
MODIFICATION OF SALT TASTER01DC000882 · NIDCD · MONELL CHEMICAL SENSES CENTER · PI BACHMANOV, ALEXANDER A · 1990 to 2013
$4.7M
MODEL FOR SENSITIVE PERIODS IN EARLY FLAVOR LEARNINGR01HD037119 · NICHD · MONELL CHEMICAL SENSES CENTER · PI MENNELLA, JULIA ANNE · 1999 to 2016
$3.9M
FACILITY CONSTRUCTION EXPANSION- MONNELL CHEMICAL SENSESC06RR018862 · NCRR · MONELL CHEMICAL SENSES CENTER · PI BEAUCHAMP, GARY K · 2003 to 2003
$3.6M
ALCOHOL EFFECT ON HUMAN LACTATION AND INFANT BEHAVIORR01AA009523 · NIAAA · MONELL CHEMICAL SENSES CENTER · PI MENNELLA, JULIE A · 1998 to 2007
$1.9M
Cortical Connectivity Using Magnetic Source ImagingF31DC006762 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DALAL, SARANG S · 2004 to 2006
$87k
NCRR NIH HHS C06 RR018862NIAAA NIH HHS R01 AA09523NICHD NIH HHS R01 HD037119NICHD NIH HHS R01 HD37119NIDCD NIH HHS F31 DC006762NIDCD NIH HHS P50 DC006760NIDCD NIH HHS P50 DC006762NIDCD NIH HHS P50 DC06760NIDCD NIH HHS R01 DC000882NIDCD NIH HHS R01 DC00882
6 · The paper itself

Abstract

backgroundActive pharmaceutical ingredients that taste bitter and/or irritate the mouth and throat are aversive to children as well as many adults. Effective methods of avoiding unpleasant tastes for adults (eg, encapsulating the medicine in pill, capsule, or tablet form) are problematic because many children cannot or will not swallow these. The unpalatable flavor of the medicine can thwart the benefits of even the most powerful of drugs. Failure to consume medication may do the child harm and can even be life-threatening.

objectivesThis article provides an overview of the current knowledge of the sensory capabilities and preferences of children as it relates to flavor, defined here as the combined input of taste, smell, and chemical irritation. The methods used to evaluate flavor perception in children are reviewed. Recent scientific advances are summarized that shed light on why the bitter taste of oral pharmaceuticals is an ongoing formulation problem and how discoveries of novel flavor molecules and modulators of bitter tastes hold considerable promise for the future. Alternative methods for evaluation of the palatability of medicines are described.

methodsThe Eunice Kennedy Shriver National Institute of Child Health and Human Development sponsored a Pediatric Formulation Initiative workshop on December 6 and 7, 2005, in Bethesda, Maryland. Information for this article was gathered from literature reviews that were then discussed during this workshop as well as during several conference calls with the Taste and Flavor Working Group members. Terms for the MEDLINE search (1970-2007) included infant, children, taste, olfaction/smell, flavor, chemical senses, palatability, sensory testing, pharmaceutical, and medicines.

resultsChildren have well-developed sensory systems for detecting tastes, smells, and chemical irritants, and their rejection of unpalatable medications is a reflection of their basic biology. Sugars, salt, and other substances reportedly reduce the bitterness of several pharmaceuticals. Adding pleasant flavor volatiles such as bubble gum may help induce children to consume a medicine, but such volatile compounds are not effective in suppressing the strong bitter tastes associated with some medications. Also, because individual experiences and culture mainly determine which odors are attractive, a universally appealing volatile flavoring agent may be difficult to identify. Sensory panelists who are sensitive to the pediatric palate, which is different from adults, and new techniques involving animal models, isolated parts of the receptor cells, and even electronic devices that detect taste and flavor are among the tools that may be used to evaluate the palatability of medications and predict compliance among pediatric populations.

conclusionsAlthough there are no easy solutions to this dilemma, children's acceptance of many medicines can be improved by applying the knowledge gleaned from basic research in the chemical senses. Further development and validation of sensory methods will provide a better understanding of the sensory world of the child. This understanding, combined with new technologies and results of animal model studies, will enhance drug acceptance and compliance in pediatric populations. A better understanding of the scientific basis for distaste and how to ameliorate it is a public health priority.

Indexed as

Administration, OralAnimalsChildChild Health ServicesDrug IndustryDrug MonitoringHumansPediatricsPharmaceutical PreparationsTechnology, PharmaceuticalPharmaceutical Preparations

Identifiers

PMID19108800
PMCPMC2744307
OpenAlexW2152582845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.